Q3 2023 Holdings
Filed 2023-11-14 | 30 holdings | $611.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $132.9M | 3,003,668 | 21.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $88.1M | 3,200,000 | 14.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $66.4M | 1,302,407 | 10.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $52.3M | 3,600,000 | 8.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $40.5M | 2,956,053 | 6.6% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $30.3M | 1,818,657 | 5.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $23.3M | 5,953,825 | 3.8% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $22.6M | 3,932,082 | 3.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $22.2M | 3,133,193 | 3.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $21.5M | 2,210,125 | 3.5% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $12.7M | 2,000,000 | 2.1% |
| Acelyrin Inc | COM | 00445A100 | $12.2M | 1,200,000 | 2.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $11.1M | 12,022,957 | 1.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $10.7M | 699,681 | 1.8% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $10.4M | 3,281,313 | 1.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $8.6M | 957,502 | 1.4% |
| Burning Rock Biotech LTD | SPONSORED ADS | 12233L107 | $8.2M | 8,500,000 | 1.3% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $7.4M | 500,000 | 1.2% |
| Syndax Pharmaceuticals Inc(SNDX)Call | COM | 87164F105 | $5.8M | 400,000 | 0.9% |
| Sutro Biopharma Inc | COM | 869367102 | $5.4M | 1,552,675 | 0.9% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $5.1M | 1,068,527 | 0.8% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $4.7M | 730,472 | 0.8% |
| Immunovant Inc(IMVT)Put | COM | 45258J102 | $3.8M | 100,000 | 0.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $2.9M | 235,176 | 0.5% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $1.2M | 473,975 | 0.2% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $434.0K | 535,005 | 0.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $208.2K | 250,000 | 0.0% |
| Travere Therapeutics Inc(TVTX)Call | COM | 89422G107 | $135.0K | 15,100 | 0.0% |
| Neoleukin Therapeutics Inc | COM NEW | 64049K203 | $94.9K | 24,037 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $43.4K | 90,058 | 0.0% |